secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2026-09-09T21:00:13+00:00
Accession:  0001493152-26-041978
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack settles Alto debt dispute with $2M cash and $2M convertible note
---------------------------------------------------------------------------

- Settlement with Alto resolves ~$10.9M asserted debt from Apimeds Pharmaceuticals; Glucotrack and others jointly liable.
- Pays $2.0M initial cash, issues $2.0M convertible note (5% interest, quarterly $500k payments from Nov 30, 2026 to Aug 31, 2027), plus up to $125k legal fees.
- Note convertible into GCTK common at $2.98/share, subject to 9.99% beneficial ownership cap and Nasdaq limits.
- Alto's release effective upon full payment; default triggers acceleration and increased interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226041978/0001493152-26-041978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226041978/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer